Orchestra BioMed Holdings, Inc.
OBIO Nasdaq
SEC CIK 1814114
Follow Orchestra BioMed
Weekly email: filings, results, news
Revenue, last quarter
$88K
−89.5% vs same quarter last year
Net income
−$23.8M
−22.7% vs same quarter last year
EPS, diluted
−$0.38
+24% vs same quarter last year
Operating cash flow
−$19.3M
−24.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $33.5M | −$52.7M |
| FY24 | $2.6M | −$61M |
| FY23 | $2.8M | −$49.1M |
| FY22 | $3.5M | −$33.6M |
| FY21 | - | −$378.8K |
| FY20 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 99.4% | −154.7% | −157.4% |
| FY24 | 92.3% | −2437.5% | −2313.3% |
| FY23 | 93.3% | −1866.2% | −1779.7% |
| FY22 | 94% | −924.3% | −951.3% |
| FY21 | - | - | - |
| FY20 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$49.5M |
| FY24 | −$50.8M |
| FY23 | −$46.2M |
| FY22 | −$29.9M |
| FY21 | - |
| FY20 | - |
- Orchestra BioMed
- Healthcare median
Show the numbers
| Year | Orchestra BioMed | Healthcare median |
|---|---|---|
| FY25 | −157.4% | −66.4% |
| FY24 | −2313.3% | −87% |
| FY23 | −1779.7% | −128.5% |
| FY22 | −951.3% | −143.6% |
| FY21 | - | −137.7% |
| FY20 | - | −134.3% |
News
No stories filed under Orchestra BioMed yet - coverage appears here as the news feed clusters it.